• Topics

  • Formats

The care continuum from drug discovery to commercialization is becoming increasingly patient-focused, with pharmaceutical and biotech companies recognizing the profound impact of understanding and incorporating patient needs and experiences at every stage.

Historically, drug development was a process dominated by scientific and clinical considerations focused primarily on molecular and clinical aspects with little regard for the patient experience. The primary goal? Demonstrate efficacy and safety through rigorous clinical trials and satisfy regulatory requirements for market approval.

The paradigm is shifting. Dramatically.

You are attempting to log out of MyMA

Do you really want to log out?